A recent study of injectable pre-exposure prophylaxis found that twice-yearly injections of lenacapavir — marketed as Yeztugo by Gilead Sciences — do not have clinically significant interactions with ...

A Pfizer drug for growth hormone deficiency has bounced back from an FDA rejection to finally win regulatory approval, clearing the way for the pharmaceutical giant to compete against a smaller rival ...

The FDA approved long-acting injectable somatrogon (Ngenla) for pediatric human growth hormone deficiency, developers Pfizer and OPKO Health announced this week. Somatrogon is indicated for children ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved long-acting once-weekly somatrogon for children with growth hormone deficiency. Somatrogon was ...

(Reuters) -The U.S. Food and Drug Administration has approved Pfizer Inc and partner OPKO Health Inc's treatment for growth hormone deficiency in children, the companies said on Wednesday. The ...

CHICAGO (AP) -- Human growth hormone is being studied by researchers but remains unproven as a youth elixir. TIME TO GROW: The pituitary gland produces HGH, which helps children grow and is important ...

Human growth hormone (HGH) is a hormone that’s essential to our development. Most people produce enough HGH throughout their lifetime. But for those with a deficiency in growth hormone (or a few other ...

The US Food and Drug Administration (FDA) has approved lonapegsomatropin (Skytrofa, Ascendis Pharma), the first weekly subcutaneous injectable growth hormone for children with growth hormone ...

A phase 3 trial has found Pfizer and Opko Health’s once-weekly growth hormone deficiency (GHD) treatment imposes less of a burden than the established daily drug Genotropin. The readout comes one year ...

Genexine’s once-weekly growth hormone has matched daily injections in a pivotal trial in China, teeing it and its partners I-Mab and Jumpcan up to file for approval next year and prepare to launch the ...

Needle-Free Growth Hormone Support via Telehealth - Platform Analysis Compares Compounded Prescription Tablets vs. Injectable Format as Consumer Search Volume for "Sermorelin Alternative" Climbs 340% ...